Ranbaxy gets USFDA nod to sell BP drug

By Sources   |   Thursday, 15 September 2005, 07:00 Hrs
Printer Print Email Email
NEW DELHI: India’s biggest pharma company Ranbaxy Laboratories has received U.S. Food and Drug Administration’s approval for selling Benazepril Hydrochloride and Hydroclorothiazide, a high blood pressure drug in the U.S. market Ranbaxy had got tentative approval for the drug in 2004 for various dosage forms from five mg to 25 mg. The company had yesterday announced the setting up of its subsidiary in Italy to gain further foothold in the European market.

SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..